AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9258847 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric training (C‐E/C, n = 13)
Number of subjects: 37
Study 9258847 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (C‐E/E, n = 13)
Number of subjects: 37
Study 9258847 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of concentric and eccentric training (C‐E/‐E, n = 11)
Number of subjects: 37
Study 9258847 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 37
Study 8336751 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg per day)
Number of subjects: 370
Study 8336751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study 3522723 — intervention group
Group type: EXPERIMENTAL
Intervention: Single vaginal application of a suppository containing 10 mg of 9‐deoxo‐16‐PGE2
Number of subjects: 0
Study 3522723 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate side effects occurred in the majority of treated patients
Number of subjects: 0
Study 30115670 — intervention group
Group type: EXPERIMENTAL
Intervention: Multibite (MB) forceps
Number of subjects: 21
Study 30115670 — intervention group
Group type: COMPARATOR
Intervention: Single-bite (SB) forceps
Number of subjects: 21
Study 27474961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 20-70mg
Number of subjects: 201
Study 27474961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 25103303 — intervention group
Group type: EXPERIMENTAL
Intervention: RDTs with basic clinician training (1 day)
Number of subjects: 3982
Study 25103303 — intervention group
Group type: EXPERIMENTAL
Intervention: RDTs with enhanced clinician training (3 days)
Number of subjects: 3982
Study 25103303 — intervention group
Group type: COMPARATOR
Intervention: Control group (current practice with microscopy)
Number of subjects: 3982
Study 22376226 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision restoration therapy (VRT) combined with active tDCS
Number of subjects: 0
Study 22376226 — intervention group
Group type: COMPARATOR
Intervention: Vision restoration therapy (VRT) paired with sham tDCS
Number of subjects: 0
Study 22376226 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS combined with VRT
Number of subjects: 0
Study 22376226 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS paired with VRT
Number of subjects: 0
Study 19581542 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol topical oral syrup (2 xylitol [4.00-g] doses and 1 sorbitol dose) administered twice a day (Xyl-2x group)
Number of subjects: 100
Study 19581542 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol topical oral syrup (3 xylitol [2.67-g] doses) administered thrice a day (Xyl-3x group)
Number of subjects: 100
Study 19581542 — intervention group
Group type: COMPARATOR
Intervention: Control syrup (1 xylitol [2.67-g] dose and 2 sorbitol doses)
Number of subjects: 100
Study 17456686 — intervention group
Group type: EXPERIMENTAL
Intervention: USG alone (Group U)
Number of subjects: 72
Study 17456686 — intervention group
Group type: COMPARATOR
Intervention: USG combined with neurostimulation (Group S)
Number of subjects: 72
Study 15006037 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental subjects (multiple motor learning experiences)
Number of subjects: 0
Study 15006037 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (limited motor learning experiences)
Number of subjects: 0
Study 15006037 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental subjects
Number of subjects: 0
Study 11815975 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment in older cohorts (age > 70 years)
Number of subjects: 515
Study 11815975 — intervention group
Group type: EXPERIMENTAL
Intervention: Older cohorts (age > 70 years)
Number of subjects: 515
Study 11815975 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients in the oldest cohort (age > 70 years)
Number of subjects: 515
Study 10847988 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (program promoting social competence)
Number of subjects: 165
Study 10847988 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study 7752587 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-1, 50 micrograms/kg body weight
Number of subjects: 18
Study 7752587 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-1, 100 micrograms/kg body weight
Number of subjects: 18
Study 2271202 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.1 MAC)
Number of subjects: 32
Study 2271202 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0.85%)
Number of subjects: 32
Study 2271202 — intervention group
Group type: COMPARATOR
Intervention: Enflurane (1.85%)
Number of subjects: 32
Study 2271202 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (1.27%)
Number of subjects: 32
Study 6446314 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 200 mg twice daily
Number of subjects: 40
Study 6446314 — intervention group
Group type: COMPARATOR
Intervention: Oxytetracycline 250 mg twice daily
Number of subjects: 40
Study 30882339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise program (30 minutes, 5 days per week)
Number of subjects: 0
Study 30882339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Exercise program (60 minutes, at least 3 days a week)
Number of subjects: 0
Study 30882339 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27777183 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of butter and margarine
Number of subjects: 595
Study 27777183 — intervention group
Group type: EXPERIMENTAL
Intervention: Total vitamin D intake
Number of subjects: 595
Study 27777183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish and shellfish intake
Number of subjects: 595
Study 27777183 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall vitamin D intake from foods
Number of subjects: 595
Study 26863502 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (8 mL/h)
Number of subjects: 24
Study 26863502 — intervention group
Group type: COMPARATOR
Intervention: Automated hourly boluses (8 mL/bolus)
Number of subjects: 24
Study 23975091 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography analysis of fascial thickness
Number of subjects: 53
Study 23975091 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography analysis of sub-layers of fascia
Number of subjects: 53
Study 23975091 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography analysis of SCM fascia
Number of subjects: 53
Study 22407438 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 0
Study 22407438 — intervention group
Group type: COMPARATOR
Intervention: Adolescent-focused therapy (AFT)
Number of subjects: 0
Study 19240517 — intervention group
Group type: EXPERIMENTAL
Intervention: Quilting suture (Group A)
Number of subjects: 30
Study 19240517 — intervention group
Group type: COMPARATOR
Intervention: No quilting suture (Group B)
Number of subjects: 30
Study 17513814 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral topotecan 2.3 mg/m2/d on days 1 through 5 every 21 days
Number of subjects: 309
Study 17513814 — intervention group
Group type: COMPARATOR
Intervention: IV topotecan 1.5 mg/m2/d on days 1 through 5 every 21 days
Number of subjects: 309
Study 15175536 — intervention group
Group type: EXPERIMENTAL
Intervention: Omni cigarette
Number of subjects: 34
Study 15175536 — intervention group
Group type: COMPARATOR
Intervention: Own cigarettes
Number of subjects: 34
Study 11445471 — intervention group
Group type: EXPERIMENTAL
Intervention: Durasphere
Number of subjects: 355
Study 11445471 — intervention group
Group type: COMPARATOR
Intervention: Bovine collagen
Number of subjects: 355
Study 9520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone, polymyxin B (6,000 U/ml), and 0.5% neomycin 4 times a day for 1 week after RK or PRK
Number of subjects: 82
Study 9520191 — intervention group
Group type: COMPARATOR
Intervention: Polymyxin B (6,000 U/ml) and 0.5% neomycin for 1 week after RK or PRK
Number of subjects: 82
Study 9520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone, polymyxin B (6,000 U/ml), and 0.5% neomycin 4 times a day for 15 days after LASIK
Number of subjects: 82
Study 9520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (PTK)
Number of subjects: 82
Study 9520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Microperforations during RK
Number of subjects: 82
Study 9520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal bleeding during RK
Number of subjects: 82
Study 8206767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulation at 3 hours after cardiac angiogram
Number of subjects: 39
Study 8206767 — intervention group
Group type: COMPARATOR
Intervention: Ambulation at 6 hours after cardiac angiogram
Number of subjects: 39
Study 2914543 — intervention group
Group type: EXPERIMENTAL
Intervention: Salsalate (1.5 g twice a day)
Number of subjects: 10
Study 2914543 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated aspirin (650 mg four times a day)
Number of subjects: 10
Study 31423722 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 31423722 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 0
Study 29058298 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation A
Number of subjects: 0
Study 29058298 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation B
Number of subjects: 0
Study 29058298 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 0
Study 29058298 — intervention group
Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 0
Study 25886590 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined diet and PA intervention
Number of subjects: 183
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-week shoulder motion restriction band
Number of subjects: 109
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week shoulder motion restriction band
Number of subjects: 109
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week shoulder motion restriction band
Number of subjects: 109
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact sports
Number of subjects: 109
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact sports
Number of subjects: 109
Study 23524151 — intervention group
Group type: EXPERIMENTAL
Intervention: No sport activities
Number of subjects: 109
Study 21496977 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable cast walker boot (n=12)
Number of subjects: 23
Study 21496977 — intervention group
Group type: COMPARATOR
Intervention: Total contact cast (n=11)
Number of subjects: 23
Study 19840530 — intervention group
Group type: COMPARATOR
Intervention: EREM alone
Number of subjects: 39
Study 19840530 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dose + flush + 3-minute wait + EREM
Number of subjects: 39
Study 19840530 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dose + flush + 10-minute wait + EREM
Number of subjects: 39
Study 19840530 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dose + flush + 15-minute wait + EREM
Number of subjects: 39
Study 19840530 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dose + 3-minute wait + EREM
Number of subjects: 39
Study 18473974 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0
Study 18473974 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study 15230080 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 16
Study 11211199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretransplant erythropoietin treatment aimed at reaching a normal hemoglobin concentration (Hb) (135-160 g/liter)
Number of subjects: 416
Study 11211199 — intervention group
Group type: COMPARATOR
Intervention: EPO treatment aimed at maintaining subnormal Hb (90-120 g/liter)
Number of subjects: 416
Study 11211199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (normal Hb and subnormal Hb)
Number of subjects: 416
Study 9484928 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard approach (SVC catheter via subclavian/internal jugular vein or cephalic/external jugular vein cut-down)
Number of subjects: 158
Study 9484928 — intervention group
Group type: COMPARATOR
Intervention: Alternative approach (SVC catheter on forearm via basilic vein cut-down and IVC catheter in abdominal region via great saphenous vein cut-down)
Number of subjects: 158
Study 9484928 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard approach
Number of subjects: 158
Study 9484928 — intervention group
Group type: COMPARATOR
Intervention: Alternative approach
Number of subjects: 158
Study 8592965 — intervention group
Group type: EXPERIMENTAL
Intervention: S-(+)-ketamine
Number of subjects: 40
Study 8592965 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 40
Study 2552067 — intervention group
Group type: EXPERIMENTAL
Intervention: HA/TTC (Periograf/tetracycline)
Number of subjects: 10
Study 2552067 — intervention group
Group type: EXPERIMENTAL
Intervention: b‐TCP/TTC (Synthograft/tetracycline)
Number of subjects: 10
Study 2552067 — intervention group
Group type: EXPERIMENTAL
Intervention: FDBA/TTC (freeze‐dried bone allograft/tetracycline)
Number of subjects: 10
Study 2552067 — intervention group
Group type: EXPERIMENTAL
Intervention: All graft materials (HA/TTC, b‐TCP/TTC, FDBA/TTC)
Number of subjects: 10
Study 104349 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.414 g ethanol/kg body weight
Number of subjects: 40
Study 104349 — intervention group
Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 40
Study 31442105 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 0
Study 31442105 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 0
Study 30376051 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted DOAC strategy (UG)
Number of subjects: 200
Study 30376051 — intervention group
Group type: COMPARATOR
Intervention: Interrupted by one dose strategy (IG)
Number of subjects: 200
Study 28403523 — intervention group
Group type: EXPERIMENTAL
Intervention: Full surface ablation at 209 μm
Number of subjects: 10
Study 28403523 — intervention group
Group type: EXPERIMENTAL
Intervention: Full surface ablation at 144 μm
Number of subjects: 10
Study 28403523 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional ablation
Number of subjects: 10
Study 28403523 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study 27330157 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐1BB ligand and Gal‐9 co-incubation with stimulated mononuclear cells
Number of subjects: 109
Study 27330157 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAM17 inhibitor
Number of subjects: 109
Study 27330157 — intervention group
Group type: COMPARATOR
Intervention: Plasma levels of s4‐1BB
Number of subjects: 109
Study 27330157 — intervention group
Group type: COMPARATOR
Intervention: Baseline plasma levels of s4‐1BB
Number of subjects: 109
Study 27330157 — intervention group
Group type: COMPARATOR
Intervention: DAS28-CRP
Number of subjects: 109
Study 23834346 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition one (CS+ 'part') with 12 aversive US images
Number of subjects: 103
Study 23834346 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition two (CS+ 'some') with 12 aversive US images
Number of subjects: 103
Study 23834346 — intervention group
Group type: COMPARATOR
Intervention: CS- 'cylinder' with 12 neutral images
Number of subjects: 103
Study 23834346 — intervention group
Group type: EXPERIMENTAL
Intervention: Disgust propensity (DP)
Number of subjects: 103
Study 23834346 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affective responding to the US
Number of subjects: 103
Study 20549501 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily
Number of subjects: 168
Study 20549501 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg once daily
Number of subjects: 168
Study 20549501 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 300 mg three times daily
Number of subjects: 168
Study 19576311 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (OMT) + percutaneous coronary intervention (PCI)
Number of subjects: 2287
Study 19576311 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 2287
Study 17493468 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DESs)
Number of subjects: 1520
Study 17493468 — intervention group
Group type: COMPARATOR
Intervention: Bare Metal Stents (BMSs)
Number of subjects: 1520
Study 15271744 — intervention group
Group type: EXPERIMENTAL
Intervention: Inversion (I)
Number of subjects: 100
Study 15271744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantar flexion (PF)
Number of subjects: 100
Study 15271744 — intervention group
Group type: EXPERIMENTAL
Intervention: Eversion (E)
Number of subjects: 100
Study 15271744 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion (DF)
Number of subjects: 100
Study 11287381 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy subjects
Number of subjects: 43
Study 11287381 — intervention group
Group type: COMPARATOR
Intervention: Spastic patients
Number of subjects: 43
Study 8882469 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 cycles of low-dose CMF (100 mg CPA orally on days 1 to 14, 20 mg MTX and 500 mg 5-FU intravenously on days 1 and 8 of each cycle)
Number of subjects: 176
Study 8882469 — intervention group
Group type: COMPARATOR
Intervention: CPA plus FT (100 mg CPA and 600 mg FT orally each day for one year)
Number of subjects: 176
Study 1985045 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 32
Study 1985045 — intervention group
Group type: COMPARATOR
Intervention: Control group (nontreated)
Number of subjects: 32
Study 6841947 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with common duct stones and recurrent pancreatitis
Number of subjects: 0
Study 6841947 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31200828 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (intermittent schedule on days 2–19)
Number of subjects: 62
Study 31200828 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (continuous schedule on days 1–21)
Number of subjects: 62
Study 31200828 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 62
Study 26194113 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial Post-Discharge Intervention Program delivered by social workers
Number of subjects: 3
Study 27927660 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 60
Study 27927660 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study 24197291 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (1.0 μg/kg/min)
Number of subjects: 60
Study 24197291 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.25 μg/kg/min)
Number of subjects: 60
Study 24197291 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 60
Study 24197291 — intervention group
Group type: COMPARATOR
Intervention: TEA
Number of subjects: 60
Study 24197291 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver's own PIM use
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse caregivers
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic caregivers
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of years that the caregiver has lived in the United States
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased caregiver age
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: PIM use in dementia patients
Number of subjects: 566
Study 22683399 — intervention group
Group type: EXPERIMENTAL
Intervention: PIM use in caregivers
Number of subjects: 566
Study 19438730 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 571
Study 17822506 — intervention group
Group type: EXPERIMENTAL
Intervention: Eflornithine 13.9% cream
Number of subjects: 0
Study 15537680 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 0
Study 15537680 — intervention group
Group type: COMPARATOR
Intervention: Social work
Number of subjects: 0
Study 12510955 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbicort® (budesonide and formoterol in a single inhaler)
Number of subjects: 0
Study 9797624 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO and iron (EPO + iron), 1200 IU/kg/week of r‐HuEPO plus 20 mg/kg/week of intravenous iron
Number of subjects: 63
Study 9797624 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO alone (EPO), 1200 IU/kg/week
Number of subjects: 63
Study 9797624 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 9797624 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO + iron
Number of subjects: 63
Study 9797624 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO
Number of subjects: 63
Study 7613894 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 XaI units of dalteparin
Number of subjects: 2070
Study 7613894 — intervention group
Group type: COMPARATOR
Intervention: 2500 XaI units of dalteparin
Number of subjects: 2070
Study 2179780 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 32
Study 2179780 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation plus less ibuprofen
Number of subjects: 32
Study 2179780 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 32
Study 2179780 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg four times a day
Number of subjects: 32
Study 7001230 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 467